NCT04626414View on ClinicalTrials.gov

Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

November 13, 2020

Study Completion Date

November 13, 2020

Conditions
Anemia, Iron Deficiency
Interventions
DRUG

Ferric maltol capsule

single dose of 30 mg capsule

DRUG

Ferric maltol suspension

single dose of 30mg (5ml) oral suspension

Trial Locations (1)

45227

Medpace Clinical Pharmacology Unit, Cincinnati

Sponsors
All Listed Sponsors
lead

Shield Therapeutics

INDUSTRY

NCT04626414 - Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers | Biotech Hunter | Biotech Hunter